Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-13

FDA Approved: ALLERGY RELIEF — Supplemental Application (Prodose, Inc)

View source ↗

Summary

FDA approved a supplemental application for ALLERGY RELIEF (cetirizine hydrochloride) by Prodose, Inc, authorizing a change under theANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLERGY RELIEF (cetirizine hydrochloride)

Snippet

SUPPL AP for ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE)